Anacor, Valeant Pharmaceuticals infectious news

An arbitrator awarded Anacor $100 million in damages as part of a contract dispute with Valeant. The dispute covers a

Read the full 207 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE